Mao L - Search Results

1

The BATTLE trial: personalizing therapy for lung cancer.

Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR Jr, Tsao A, Stewart DJ, Hicks ME, Erasmus J Jr, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK. Kim ES, et al. Among authors: mao l. Cancer Discov. 2011 Jun;1(1):44-53. doi: 10.1158/2159-8274.CD-10-0010. Epub 2011 Jun 1. Cancer Discov. 2011. PMID: 22586319 Free PMC article. Clinical Trial.

2

Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.

Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L. Soria JC, et al. Among authors: mao l. Cancer Res. 2002 Jan 15;62(2):351-5. Cancer Res. 2002. PMID: 11809677

3

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR. Soria JC, et al. Among authors: mao l. Clin Cancer Res. 2002 May;8(5):1178-84. Clin Cancer Res. 2002. PMID: 12006535

4

A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.

Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q. Shen H, et al. Among authors: mao l. Cancer Res. 2002 Sep 1;62(17):4992-5. Cancer Res. 2002. PMID: 12208751

5

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.

Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR. Wang L, et al. Among authors: mao l. Clin Cancer Res. 2002 Sep;8(9):2883-9. Clin Cancer Res. 2002. PMID: 12231532

6

Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK, Mao L. Hassan KA, et al. Among authors: mao l. Cancer Res. 2002 Nov 15;62(22):6414-7. Cancer Res. 2002. PMID: 12438226

7

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.

Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY. Chang YS, et al. Among authors: mao l. Clin Cancer Res. 2002 Dec;8(12):3669-75. Clin Cancer Res. 2002. PMID: 12473575

8

Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.

Papadimitrakopoulou VA, Liu DD, Mao L, Shin DM, El-Naggar A, Ibarguen H, Lee JJ, Hong WK, Hittelman WN. Papadimitrakopoulou VA, et al. Among authors: mao l. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1605-10. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496051 Clinical Trial.

9

Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.

Soria JC, Xu X, Liu DD, Lee JJ, Kurie J, Morice RC, Khuri F, Mao L, Hong WK, Lotan R. Soria JC, et al. Among authors: mao l. J Natl Cancer Inst. 2003 Jan 15;95(2):165-8. doi: 10.1093/jnci/95.2.165. J Natl Cancer Inst. 2003. PMID: 12529350

10

Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS, Mao L, Khuri FR. Soria JC, et al. Among authors: mao l. Clin Cancer Res. 2003 May;9(5):1785-91. Clin Cancer Res. 2003. PMID: 12738735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,747 results

Search Page

Filters